WST - Cindy ReissClark Exhibits Confidence With An Acquisition Of West Pharmaceutical Servs Stock Options | Benzinga
In a new SEC filing on February 22, it was unveiled that ReissClark, Chief Commercial Officer at West Pharmaceutical Servs (NYSE:WST), acquired stock options for 2,411 shares.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that ReissClark, Chief Commercial Officer at West Pharmaceutical Servs, a company in the Health Care sector, acquired stock options for 2,411 shares of WST. The options allow ReissClark to buy the company's stock at $350.18 per share.
West Pharmaceutical Servs shares are currently trading down by 0.0%, with a current price of $359.9 as of Friday morning. This brings the total value of ReissClark's 2,411 shares to $23,434.
Discovering West Pharmaceutical Servs: A Closer Look
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Financial Milestones: West Pharmaceutical Servs's Journey
Revenue Growth: West Pharmaceutical Servs displayed positive results in 3 months. As of 31 December, 2023, ...